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Abstract 
Background 
Self-monitoring blood glucose (SMBG) is facilitated by application available to analyze these data. They are 
mainly based on descriptive statistical analyses. In this study, we are proposing a method inspired by artificial 
intelligence algorithm for displaying glycemic data in an intelligible way with high-level information that is 
compatible with the short duration allocated to medical visits. 
Method 
We are proposing a display method based on a numerical glycemic data conversion using a qualitative color 
scale that exhibits the patient's overall glycemic state. Moreover, a machine learning algorithm inputs these 
displays to exhibit recurrent glycemic pattern over configurable extended time period.  
Results 
A demonstrator of our method, output as a glycemic map, could be used by the physician during quarterly 
patient consultations. We have tested this methodology retrospectively, on a database in order to observe the 
behavior of our algorithm.  In some data files we were able to highlight some of the glycemic patterns 
characteristics that remain invisible on the tabular representations or through the use of descriptive statistic.   In a 
next step the interpretation will have to be done by physicians to confirm they underlie knowledge. 
Conclusions 
Our approach with artificial intelligence algorithm paired up with graphical color display allow a large database 
fast analysis to provide insights on diabetes knowledge. The next steps are first to set up a clinical trial to 
validate this methodology with dedicated patients and physicians then we will adapt our methodology for the 
huge data sets generated by continuous glycemic measurement (CGM) devices.  
  
4 
Introduction  
Diabetes is a major problem
1,2
 in terms of both public health and economic costs for all affected countries. This 
study focuses on patients suffering from type 1 diabetes. For this type, many studies recommend and 
demonstrate that the use of self-monitoring blood glucose (SMBG) meters offers significant progress for 
managing diabetes in terms of reducing hyperglycemic and hypoglycemic periods. Understanding the 
significance of self-monitoring data is greatest when glycemic data collection has been organized in a structured 
manner
3,4,5,6,7
. The structure of these data is enhanced by adding key information, such as daily life information. 
The use of more recent personal glucometers makes it easier to record information (semiautomatic process). All 
these data should be taken into account upon each physician's visit in order to yield objective quantitative and 
qualitative information on glycemic events that occurred over the period prior to the visit, thus allowing the 
physician to establish a detailed diagnosis. The amount of data recorded over a 3-month period may however 
contain several thousand measurement points. This mass of information-considered as Big Data- must then be 
preprocessed with analysis software to provide the physician with a summary overview. Some manufacturers of 
self-monitoring tools provide the basic analysis and data visualization software with their glucometers. These 
software programs perform statistical analyses on various time slots during the day or on specific days of the 
week
8,9,10
. Statistical analyses are often in a conventional descriptive format and remain largely unused by 
practitioners during consultation and decision-making
11
. In general, these calculations are restricted to the mean, 
median, standard deviation and inter-quartile (between 1
st
 and 3
rd
 quartiles); they are presented in tabular format. 
These tools also feature graphical display modes that use conventional statistical representations; a few such 
modes will be described below. The time series of blood glucose values are often shown by a scatter plot Figure 
Figure 1. Graph of temporal variation of glycemia superposed with daily mean values (critical hypoglycemia threshold set 
to 50mg/dl) (17) Accu-Chek Smart Pix software V3.0 Roche 
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1. The scatter plot is often superimposed with other information, as is the case with several diabetes management 
software packages. For example, the average daily value gives an overview of the glycemic trend over an 
extended period. This value is often qualified by the standard deviation, which provides critical information on 
the variability of blood glucose. Hirsch
12
 and Kovatchev
13
 used this information to indicate the level of glycemic 
control a long-term risks as a more reliable indicator than HbA1c taken on its own. Using the mean value and 
standard deviation has drawbacks however: very sensitive to extreme outliers and the interpretation of standard 
deviation is biased due to the non-Gaussian, yet not right-skewed, distribution of blood glucose values. 
According to Rodbard et al. the median would be more representative than the average because of its lower 
sensitivity to exceptional extreme values, as opposed to the average when the number of measurements is 
sufficient. Also according to Rodbard et al., the overlay of the median line and the 1
st
 and 3
rd
 quartiles on the 
graph of the daily blood glucose values, when correlated with meal times and dedicated time segments, is more 
relevant and understandable than a histogram or distribution of repetitions (frequency distribution), which results 
in information loss on specific observations. Histograms are used to depict the distribution of blood glucose 
values over time and to identify the rate of hyperglycemia and hypoglycemia associated with a color code 
Figure 2. This representation with histograms clearly highlights the asymmetric distribution curve (i.e. non-
Gaussian) "sliding" to the right. One consequence of this asymmetry in the time series representation Figure 1 is 
a graphical minimization of hypoglycemia as compared to hyperglycemia, which appears to be more 
accentuated. Correcting this bias by applying an operator, such as the logarithm (log10) may compensate for the 
Figure 2. Density of distribution of blood glucose values associated 
with a color code (software CoPilot V4.2 Abbott) 
6 
asymmetry and then results in a normal type data distribution
14
. Moreover, this transformation allows for the use 
of many statistical tools, in assuming data normality: blood glucose variability constitutes an essential element. 
One of the best evaluators for variability, according to Rodbard, is the IQR (or Inter-Quartile Range) is not 
sensitive to extreme values (outliers) and does not require a normal distribution. Boxplot provides a quick 
understanding of all components, as shown in Figure 3. Although helpful for its visual and synthetic layout, this 
representation remains non-intuitive for those without an extensive background in statistics. Other forms of 
graphs are often available, such as “pie”. Additional materials include data sheets in tabular format with glucose 
measurements per time slot, medications, insulin injections and other background notes. Through various 
studies
15,16
, Rodbard suggested to modify conventional methods of viewing data from SMBG in order to adapt to 
physicians' constraints during their quarterly consultations. Using a color code or "stacked bar graph", Figure 4, 
while facilitating and accelerating the interpretation of glycemic measurements over several months. This 
visualization requires a learning phase dedicated to the large, which prove to be less intuitive. Other studies 
make use of glucose measurements by adding a predictive characteristic. An alternative glucose index has been 
developed to predict abnormal glycemia as a means of optimizing diabetes treatment and monitoring. Kovatchev 
et al. introduced a new variable to determine the risk  
𝐴𝐷𝑅𝑅 =
1
𝑀
∑[𝐿𝑅𝑖 + 𝐻𝑅𝑖]    (1)
𝑀
𝑖=1
 
of hyper / hypoglycemia: ADRR, or the average daily risk range for associating a risk index with a given period : 
Equation 1 shows that the expression of this variable does not use raw glucose values but instead a standardized 
form to output the same weight to hypoglycemia as to hyperglycemia. For each glucose value, an index is then 
calculated separately for hypoglycemia (L) and hyperglycemia (H) on each day i, for averaging over the entire 
period M. This variable is used to predict abnormal glycemia (both severe hyperglycemia and severe 
2.088 
0.388 
IQR =  Q3-Q1 = 0.425 g/l 
Glycémie en g/l 
      1.0                    1.5                       2.0                       2.5 
       
       
min. 1er Quartile Médiane Moyenne 3ième Quartile Max. 
0.700 1.025 1.150 1.357 1.450 2.900 
 
IQR Q1 Q3 
3.A 
3.B 
Figure 3. Representation of the dispersion by IRQ (A) tabular form, (B) graphic boxplot type. 
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hypoglycemia), which according Kovatcev et al.  has a good level of robustness since at least three blood 
glucose measurements are required daily for 14 days. This performance has been evaluated experimentally on a 
clinical trial. On the other-hand, through use of data mining methods, Bellazzi et al. proposed a combination of 
signal processing methods and artificial intelligence tools. The first step consists of modeling the time series 
(TS) glucose values as the sum of three components: 
𝐵𝐺𝑖 = 𝑇𝑖 + 𝐶𝑖 + 𝜀𝑖        (2) 
where Ti denotes the trend component, Ci the cyclical component and εi the stochastic component. These three 
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Figure 4.  Representation of different blood glucose values according to Rodbard 2009(A) scatter plot with graphic symbols and color 
coding for 3 months, (B) color-coded stacked bar graph on dense data. 
Figure 5 Structural analysis and temporal abstraction proposed by Bellazzi et al. 2009 
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components are extracted from the data using various mathematical tools (Kalman filters, least squares, etc.). An 
artificial intelligence technique called temporal abstraction (TA) will then serve to define the temporal interval 
sets characterized by the occurrence of exceptional event(s). For example, the TA "state" will all be time 
intervals characterized by a state in {low, normal, high, very high} (in terms of blood glucose). For the TA 
"trend" among {ascending, descending}, the determination makes use of the decomposition step in Equation 1. 
This structural analysis (TS) and the temporal abstractions (TA) applied to the analysis of blood glucose time-
series data are shown in Figure 5, where Bellazzi et al.  applies a blood glucose time series on two time slots (+ 
= breakfast, O = dinner). The left-hand panels display an extraction of the Ti component from Equation 2 of the 
raw data with a red line. These trends are indicated by the superposition of yellow rectangles (upward trend) and 
white rectangles (downward trend). The graph in the upper right shows the filtration of the cyclical component 
Ci from Equation 2. It is straightforward to isolate the marked green area characterized by a TA "maximum 
sugar for breakfast" and the TA "minimum sugar at dinner", which might be viewed as a conjunctive rule. This 
relatively complex approach is far from intuitive, yet it allows extracting high-level information that is 
complementary with statistical approaches. More recent publications
18,22 
use pentagon to display multi-
parameters (5) with synthetic view Figure 6 or group different information (from different institutions, different 
devices) in a optimally organized view to minimize cognitive load and maximize effectiveness of diagnosis.  
This study seeks to develop a graphical representation that simplifies the monitoring of blood glucose levels over 
a long period (approx. 3 months) by highlighting, through data mining algorithms, recurrent glycemic patterns 
characteristic of the patient's behavior without requiring the use of calculation or prediction algorithms. This 
objective is achieved through adapting a visualization method used in other applications (temperature maps, 
DNA expression level maps) to glycemic data. To simplify the process with smart connected glucometer device 
Figure 6. Glucose pentagon representation with 5 
parameters 
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we developed a prototype application embedded with the proprietary software of the glucometer. This 
visualization is an extension of the scale developed by Richard M. Bergenstal et al.
19
 In this article they 
suggested a dashboard called AGP (Ambulatory Glucose Profile) for glucose reporting and analysis with 
numerical indexes ( Avg. Glu, %HbA1c, SD Glu, IQR Glu, Freq. for different ranges of Glu, etc…)  and nested 
time plots (for the hours of the day or days of the month). In this article we use the term profile in a different way 
than the one used by Bergenstal. We call profile a significant color pattern over time rather than an AGP report 
summarizing several metrics. 
Materials and methods 
We use anonymous glycemic data from a database made of 62 patients using several glucometer devices. The 
content collected herein included time-stamped measures of glycemia (with date, time and time slot), other 
contextual information and unrestricted comments. For this study, we only considered the values of time-
stamped glycemia for all days regardless of the number of data points they contain. The first data processing step 
consists of standardizing the data from different device brands in order to generate a unique output. For this 
purpose, we employed a matrix structure, whereby each row represents a day and each column a time slot 
number in chronological order. The correspondence between the time slot number and the time of day is 
synchronized with the glucometer definitions set by the patient though a default mapping table could be used. 
These times of day must naturally be tied to the patient's eating habits to ensure maximum relevance for the 
analysis (see Table 1). The second step entails transforming the numerical scale of blood glucose levels into a 
qualitative scale that highlights information on the patient's glycemic status rather than the numerical value of 
glycemia. To be successful, we used a color scale encoded on 6 levels (see Table 2 and Figure 7).   
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Table 2: 
Six color-coded levels  
Glycemia 
(mg/dL) 
Glycemic status Color 
>250 High hyperglycemia  
[140, 250[ Hyperglycemia  
[80, 140[ Target  
]80, 60] Hypoglycemia  
<60 High hypoglycemia  
No measure   
 
In Table 2 physicians suggest 5 categories of glycemia according to their severity. Bergenstal used a similar 
scale with 6 levels of severity. In our demonstrator these levels can be modified, if necessary, by the physician. 
The core of our process is based on artificial intelligence algorithm (AI involves machines that can perform tasks 
that are characteristic of human intelligence) to make emerge high-level meaningful information (i.e. 
knowledge). 
 
Table 1:  
Table of time slot  vs. time of day / hours 
#time slot Time of day Hours 
Time slot1 Waking up, WU Before 7 am 
Time slot2 Before breakfast, BB 7 - 10 am 
Time slot3 After breakfast, AB 10 am - noon 
Time slot4 Before lunch, BL 12 - 3 pm 
Time slot5 After lunch, AL 3 - 6 pm 
Time slot6 Before dinner, BD 6 - 9 pm 
Time slot7 After dinner, AD 9 - 11:30 pm 
Time slot8 Nighttime, NI After 11:30 
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Machine learning is simply a way of achieving AI, it is a process based on analysis of some training data sets. 
That will allow us to highlight relevant information. Machine learning is not here used to generate a predictive 
model since it has been often described that diabetes is quite complex to predict. We focus our effort in 
understanding the recorded information instead of setting any prediction. In this perspective adding more data 
samples would not necessarily improve our algorithm. For this task, we applied an algorithm that consists of 
grouping a set of multidimensional vectors according to their similarity. Each group will thus be of a 
homogeneous composition and suitable for characterization by a single consensus vector. In our case for 
example, all vectors will be the days, and each time slot will represent one dimension of the vector. In comparing 
daily returns to evaluate their similarities in terms of glycemic profile (i.e. time slot values), we obtain groups of 
similar days and can proceed to identify patients' "glycemic pattern" characteristics (depending on group size - 
cluster). With a more formal expression, we can model this problem and solve it using the K-means algorithm
20 
: 
Let 𝑥𝑛 = {𝑥1, 𝑥2, ⋯ , 𝑥𝑛}  be the set of vectors modeling n days within a space of m dimensions (time slots), as: 
 𝑥𝑖 = (𝑥𝑖
1, 𝑥𝑖
2 ⋯ 𝑥𝑖
𝑚), with cj being the vector representing the center of each cluster, the problem then is to find k 
centers of cj that minimize the following function: 
𝑗 = ∑ ∑‖𝑥𝑖
𝑗
− 𝑐𝑗‖
2
𝑛
𝑖=1
𝑘
𝑗=1
     (3) 
where ‖𝑥𝑖
𝑗
− 𝑐𝑗‖
2
 denotes the Euclidean distance between two vectors xi and cj and moreover corresponds to 
our similarity measure. Minimizing j will now be defined by an iterative calculation sequence described in the 
box below: 
Figure 7. Process raw device data (~ 400 rows) to standard glycemic matrix representation transcoded with 6 color level 
 TABLE 1 
TABLE 2 
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1. Set k dots initializing the center of each cluster cj 
2. Assign each dot xi to the nearest center cj (using the similarity 
measure) and define each cluster 
3. Once all dots are assigned to a cluster, re-calculate the position of 
the center for each cluster found (we use the mean operator here) 
4. Repeat steps 1 through 3 until the centers no longer move. 
The execution of this algorithm is illustrated in Figure 8 for m = 2 dimensions (time slots) 
To test and select clustering algorithms (unsupervised classifier) we have used the data mining workbench of 
machine learning WEKA developed by the Waikato University.  
The main parameter to challenge is K, the number of cluster that we choose to be understandable according to 
the data by experience.  
The second parameter is the type of the distance between objects to compare to achieve classification (objects 
are vectors of glycemia per day denoted by  𝑥𝑖
𝑗
). Without specific a priori knowledge we chose Euclidian 
distance which in a glance gives meaningful colored patterns. 
 
Results 
To develop a demonstrator, the algorithm has been implemented in an Android smartphone. We analyzed data 
file that we transferred to the phone one by one. The analysis was performed one set of data at a time. For all of 
them, a visualization map was processed then using K=3 for the K-mean algorithm, we had some clusters 
Assign each dot to nearest 
center and  define each cluster 
(step 2)  
3 center initialization 
(step 1) 
Assign each dot to nearest 
center and  define each cluster 
(step 2)  
re-calculate the position of 
the center for each cluster 
(step 3)  
Re-calculate centers (step 3) 
centers no longer move 
 END OF ALGORITHM 
 
C1 
C2 
C3 
Set of raw data 
Timeslot 2 
J1 (Gly T1, GlyT2) 
Timeslot 1 
INITIALISATION 1st ITERATION 2
nd
 ITERATION 3
rd
 ITERATION 
K=3 
Assign each dot to nearest 
center and  define each cluster 
(step 2)  
re-calculate the position of 
the center for each cluster 
(step 3)  
Figure 8. K-means algorithm step by step. To simplify we used only 2 time slots (2Dgraph). We identify 3 
groups of points in the scatter plot that represents 3 characteristic glycemic patterns 
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defined for every of the 62 samples. But only 19 were clearly understandable. We chose one of them as an 
example for the demonstration 
1. The analysis of raw glycemic values data in the digital matrix is obtained by means of a qualitative 
conversion according to the 6 color code, it may now be used to identify consensus glycemic pattern 
during the period between two quarterly consultations (i.e. approx. 90 days) applying k-mean algorithm. 
One example is provided in the Figure 9. This glycemic map with high variability does not, at first 
sight, reveal any general color trend. Use of the K-means algorithm on all days for k=3 (this parameter 
was found by iterative test with incremental values for k. The value used is the one that gives the most 
interpretable patterns) yields the two following groups, with each representing a dominant weekly trend. 
The first cluster, which covers 34% of days, shows that the patient is hypoglycemic before and after 
breakfast and hyperglycemic before and after dinner and then hyperglycemic and highly hyperglycemic 
at night. This glycemic map also emphasizes missing data that could also be interpreted. 
2. The second cluster- made of 24% of days- indicates that the same patient is hypoglycemic when waking 
up as opposed to hyperglycemic both before and after dinner but does not measure glycemia at night. 
These two clusters provide useful information for the physician to complete his diagnosis, which is considerably 
more difficult when just looking at glycemic raw data. 
WU  BB  AB  BL  AL  BD  AD  N 
WU : wake up,  BB : before breakf,  AB : after breakf 
BL : before lunch.    AL : after lunch    BD before dinner 
AD : after dinner      N : Night 
     Cluster (1)                Cluster (2) 
    34% of days                                       24% of days 
WU  BB  AB  BL   AL  BD  AD  N WU  BB  AB  BL   AL  BD  AD  N 
Figure 9. Highlighting weekly behavior by applying the K-mean 
algorithm 
        Before/After W.Up.                         Before /After Dinner 
       33%         22%        45%                19%           22%         59% 
  
Figure 10. Pre/post prandial analysis. 
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From another data file we could use parameters of the application to restrict the analysis for only post and pre-
prandial timeslots, the result of the clustering on the Figure 10 identify 2 dominant clusters: one for 
hypoglycemia during wake-up (45% of the days) and one for hyperglycemia during dinner period (59% of the 
days).  
 
Discussion 
We initiated this study after the physicians’ feedback of an unmet need for data visualization. Through their 
practices, recovering glucometer data was already a technical challenge. Using the device provided interface or 
previously described method for data visualization required technical options that often they could not install in 
the Hospital network. Our main goal was then to provide an easy-to use tool, interoperable, or at least used on a 
very friendly interface that would provide, in a glance, as much as much information as possible. This is why we 
did not compare our process to any other existing ones. Then the expertise of the physician would complement 
the analysis. The algorithm was supposed to pre-analyze more information than a regular human brain can do, in 
a short time and provide a visual scale according to the thresholds asked by physicians themselves. 
 
Through our methodology, we follow a two steps process. The first one is a global intuitive visualization of data 
through a color-code overview. Three technical advantages : (1) reading and interpretation are instantaneous 
(compared to a numerical value in tabular format), (2) no need for pretreating the blood glucose values to 
compensate for the "asymmetry" of hypoglycemia since the color code is neutral, (3) the reading step is 
independent of the blood glucose measurement unit (either mg/dL, mmol/L or g/L). 
The second step results in applying an machine learning algorithm that provides the physician with a thorough 
analysis of the patient's most frequent glycemic pattern based on several significant periods (e.g. weekly, pre / 
post-prandial, day of week, time slots, waking up in the morning / nighttime). This post-processed information of 
glycemic data is based on heat maps visualization; interpretation can therefore be processed very quickly with 
minimal training.  
15 
We can anticipate three levels of benefits of this methodology once deployed as a mobile appli Figure 11 
(through the pilot study; the app has been deployed on Android phone. The demo version is available upon 
request): 
1- For the physicians: During the visit, more data will be globally analyzed to overcome a specific 
behavior we noticed through patient data: the “white coat effect”.  The patient behavior in monitoring 
his glycemia could be different the month before the visit in comparison with the months before. 
Through our process, a bigger time-scale of data is considered avoiding any “cheating” or “misleading” 
on data collection.  Furthermore, data are post-processed for physician convenience, to emerge the 
knowledge on glycemic repetitive motifs and patterns that could not be qualified otherwise. 
2- For the patient: The visual representation of data should be more intuitive to understand the daily data. 
That could bring a new insight on the diabetes understanding and management. Furthermore, it should 
become a decision-making tool to help and improve any decision about daily treatment. The wide-scale 
data visualization should become for the patient an education tool to appreciate his pathology on the 
long-term. 
3- Shared decision making: the data could be contextualized on the long-term emphasizing, for example 
treatment doses, life events, and quality of life. In the long-term it would be an efficient way to prevent 
comorbidities that are quite silent and asymptomatic for patients. The algorithm is already multi-
parametric (multi dimensions) and allow the integration of various complementary variables. 
Figure 11. Two steps process of glucometer data analysis 
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This Method is consistent with other methods, since we based our analysis on usual thresholds, usual metrics and 
usual physician’s practice. Moreover this methodology could be used as a complement of any other method. 
This methodology could be adjusted to any glycemic data collection device such as continuous glucose 
measurement
21
 (CGM) devices that generated huge amount of data. This algorithm could, eventually, be adjusted 
to the use of several glucometers by one patient. 
 
Our visualization process seems to be more intuitive than the ones described by Rodbard and al. that could be 
evaluated with patients in upcoming studies. Another tool proposed by Bergenstal called AGP provide a 
dashboard with standardized metrics summarize glycemic patient profile. But the amount of information on one 
panel is not easy to read : the overall cognitive charge and perception of such tools, as already discussed by 
Bowen and al., should be of priority concern to ensure that technology by itself does not create a limitation of the 
software use. Finally, our tool does not provide -so far- any prediction process, as described by Bellazi et al.
22 
since this field seem to require a lot of contextual data to be optimized. 
 
Conclusion 
Through this work we have highlighted characteristic patterns that underlie information and potential benefits 
that must be validated by physicians in an upcoming clinical trial. Usually, one month of glycemic data is 
analyzed during the visit. With this method, we can easily analyze three months of data and even much more. 
The overall temporality of the knowledge is increased. We can anticipate that seasonal changes should appear in 
sort of glycemic patterns that impact the overall pathology evolution understanding. The next step will be to 
scale up the use of this app for Android device and to analyze the impact of this technology on patients, 
physicians and the process of shared decision making and expand our methodology for the huge data sets 
generated by continuous glycemic measurement devices.  
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